| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 106.548 | 101.122 | 114.441 | 91.107 | 72.828 | 25.441 | 95.128 | 110.726 | 41.071 | 1.096 |
| Total Income - EUR | 136.280 | 103.800 | 114.787 | 94.855 | 73.543 | 32.973 | 104.048 | 110.727 | 41.071 | 1.096 |
| Total Expenses - EUR | 154.107 | 105.287 | 111.649 | 101.666 | 70.801 | 39.726 | 92.915 | 109.561 | 43.186 | 1.167 |
| Gross Profit/Loss - EUR | -17.827 | -1.487 | 3.138 | -6.812 | 2.742 | -6.753 | 11.133 | 1.166 | -2.115 | -71 |
| Net Profit/Loss - EUR | -17.827 | -1.487 | 2.012 | -7.760 | 2.010 | -7.195 | 10.093 | 58 | -2.115 | -71 |
| Employees | 2 | 0 | 2 | 1 | 1 | 1 | 2 | 1 | 1 | 0 |
Check the financial reports for the company - Medaxim Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 42.435 | 34.906 | 53.629 | 37.765 | 28.666 | 24.029 | 11.693 | 9.947 | 9.805 | 9.750 |
| Current Assets | 54.312 | 46.304 | 44.415 | 40.070 | 44.654 | 62.294 | 70.325 | 58.508 | 56.456 | 56.064 |
| Inventories | 1.112 | 2.659 | 1.682 | 1.328 | 1.336 | 47.085 | 49.137 | 40.006 | 0 | 0 |
| Receivables | 29.988 | 31.112 | 32.126 | 26.354 | 19.298 | 14.075 | 16.805 | 6.398 | 53.750 | 53.449 |
| Cash | 23.212 | 12.533 | 10.606 | 12.389 | 24.019 | 1.134 | 4.383 | 12.104 | 2.707 | 2.615 |
| Shareholders Funds | -5.395 | -7.046 | -4.915 | -12.585 | -10.331 | -17.123 | -6.651 | -6.613 | -8.708 | -8.731 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 248 | 243 | 243 | 243 | 241 |
| Debts | 102.141 | 88.255 | 102.958 | 90.419 | 83.651 | 103.446 | 88.669 | 75.068 | 74.969 | 74.544 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4532 - 4532" | |||||||||
| CAEN Financial Year |
4711
|
|||||||||
Comments - Medaxim Srl